Pamela M. Quizon - Publications

University of South Carolina, Columbia, SC 
dopamine transporter, HIV-1 Tat, Tat protein, neuropharmacology, addiction

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Strauss MJ, Porter KD, Quizon PM, Davis SE, Lin S, Yuan Y, Martinez-Muniz GA, Sun WL, Zhan CG, Zhu J. Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function. Plos One. 17: e0275182. PMID 36170295 DOI: 10.1371/journal.pone.0275182  0.797
2022 Zhu J, Quizon PM, Wang Y, Adeniran CA, Strauss MJ, Torres AJ, Patel P, Cirino TJ, Eans SO, Hammond HR, Deliscar LS, O'Hara P, Saini SK, Ofori E, Vekariya RH, et al. SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 Tat transgenic mice. Neuropharmacology. 109239. PMID 36126727 DOI: 10.1016/j.neuropharm.2022.109239  0.748
2021 Ogata Y, Quizon PM, Nightlinger NS, Sitasuwan P, Snodgrass C, Lee LA, Meyer JD, Rogers RS. eAutomated Multi-Attribute Method Sample Preparation using High-Throughput Buffer Exchange Tips. Rapid Communications in Mass Spectrometry : Rcm. e9222. PMID 34783086 DOI: 10.1002/rcm.9222  0.207
2021 Quizon PM, Yuan Y, Zhu Y, Zhou Y, Strauss MJ, Sun WL, Zhan CG, Zhu J. Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat-inhibited Dopamine Transport. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 33537927 DOI: 10.1007/s11481-021-09984-5  0.809
2019 Sun WL, Quizon PM, Yuan Y, Strauss MJ, McCain R, Zhan CG, Zhu J. Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport. Scientific Reports. 9: 3843. PMID 30846720 DOI: 10.1038/S41598-019-39872-1  0.805
2017 Sun WL, Quizon PM, Yuan Y, Zhang W, Ananthan S, Zhan CG, Zhu J. Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter. Scientific Reports. 7: 3694. PMID 28623359 DOI: 10.1038/S41598-017-03771-0  0.622
2016 Quizon PM, Sun WL, Yuan Y, Midde NM, Zhan CG, Zhu J. Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport. Scientific Reports. 6: 39048. PMID 27966610 DOI: 10.1038/Srep39048  0.803
2016 Yuan Y, Quizon PM, Sun WL, Yao J, Zhu J, Zhan CG. Role of Histidine 547 of Human Dopamine Transporter in Molecular Interaction with HIV-1 Tat and Dopamine Uptake. Scientific Reports. 6: 27314. PMID 27250920 DOI: 10.1038/Srep27314  0.766
2016 Sun WL, Quizon PM, Zhu J. Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects. Progress in Molecular Biology and Translational Science. 137: 1-40. PMID 26809997 DOI: 10.1016/Bs.Pmbts.2015.10.017  0.353
2015 Zhu J, Yuan Y, Midde NM, Gomez AM, Sun WL, Quizon PM, Zhan CG. HIV-1 transgenic rats display an increase in [(3)H]dopamine uptake in the prefrontal cortex and striatum. Journal of Neurovirology. PMID 26501780 DOI: 10.1007/S13365-015-0391-6  0.733
2015 Yuan Y, Huang X, Midde NM, Quizon PM, Sun WL, Zhu J, Zhan CG. Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter. Acs Chemical Neuroscience. 6: 658-65. PMID 25695767 DOI: 10.1021/Acschemneuro.5B00001  0.771
2015 Midde NM, Yuan Y, Quizon PM, Sun WL, Huang X, Zhan CG, Zhu J. Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 122-35. PMID 25604666 DOI: 10.1007/S11481-015-9583-3  0.796
2014 Smallwood TL, Gatti DM, Quizon P, Weinstock GM, Jung KC, Zhao L, Hua K, Pomp D, Bennett BJ. High-resolution genetic mapping in the diversity outbred mouse population identifies Apobec1 as a candidate gene for atherosclerosis. G3 (Bethesda, Md.). 4: 2353-63. PMID 25344410 DOI: 10.1534/G3.114.014704  0.322
2014 O'Connor A, Quizon PM, Albright JE, Lin FT, Bennett BJ. Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 25: 583-99. PMID 25159725 DOI: 10.1007/s00335-014-9540-0  0.211
2014 Albright J, Quizon PM, Lusis AJ, Bennett BJ. Genetic network identifies novel pathways contributing to atherosclerosis susceptibility in the innominate artery. Bmc Medical Genomics. 7: 51. PMID 25115202 DOI: 10.1186/1755-8794-7-51  0.216
2012 Naidoo V, Karanian DA, Vadivel SK, Locklear JR, Wood JT, Nasr M, Quizon PM, Graves EE, Shukla V, Makriyannis A, Bahr BA. Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 801-13. PMID 22270809 DOI: 10.1007/S13311-011-0100-Y  0.533
Show low-probability matches.